SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-23-000106
Filing Date
2023-02-10
Accepted
2023-02-10 08:10:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 e618257_f6pos-orchard.htm F-6 POS 57625
2 e618257_ex99-ai.htm EX-99.(A)(I) 196590
3 e618257_ex99-aii.htm EX-99.(A)(II) 450273
4 e618257_ex99-b.htm EX-99.(B) 44220
  Complete submission text file 0001193805-23-000106.txt   750293
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS

Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Subject) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-227905 | Film No.: 23608605
SIC: 2836 Biological Products, (No Diagnostic Substances)